• 1. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

Professional Introduction to 2,4-Dichloro-3-methylmandelic Acid (CAS No. 1803779-89-6)

2,4-Dichloro-3-methylmandelic acid, identified by its Chemical Abstracts Service (CAS) number 1803779-89-6, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound, characterized by its dichloro and methylmandelic functional groups, exhibits unique chemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules. Its molecular structure, featuring a benzene ring substituted with chlorine atoms at the 2 and 4 positions and a mandelic acid moiety at the 3 position, contributes to its reactivity and utility in synthetic pathways.

The chemical structure of 2,4-Dichloro-3-methylmandelic acid imparts distinct characteristics that are leveraged in pharmaceutical applications. The presence of two chlorine atoms enhances its electrophilicity, making it a suitable precursor for nucleophilic substitution reactions. This property is particularly useful in the construction of more complex molecular frameworks, including heterocyclic compounds and peptidomimetics. The mandelic acid portion provides a carboxylic acid functionality, which can be further modified through esterification, amidation, or other derivatization strategies to tailor its biological activity.

In recent years, 2,4-Dichloro-3-methylmandelic acid has been explored as a key intermediate in the development of novel therapeutic agents. Its role in synthesizing pharmacophores with potential antimicrobial, anti-inflammatory, and anticancer properties has been highlighted in several scientific studies. For instance, researchers have utilized this compound to construct analogs of natural products that exhibit enhanced binding affinity to biological targets. The dichloro substitution pattern is particularly advantageous in designing molecules that interact with enzymes or receptors with high specificity.

One of the most compelling aspects of 2,4-Dichloro-3-methylmandelic acid is its versatility in medicinal chemistry. The compound serves as a building block for libraries of drug-like molecules that can be screened for biological activity. High-throughput screening (HTS) campaigns have been conducted using derivatives of this compound to identify lead candidates for further optimization. The structural features of 2,4-Dichloro-3-methylmandelic acid allow for modifications that can fine-tune pharmacokinetic properties such as solubility, bioavailability, and metabolic stability.

The synthesis of 2,4-Dichloro-3-methylmandelic acid itself is an area of active investigation. Modern synthetic methodologies have been developed to produce this compound with high yield and purity. Techniques such as palladium-catalyzed cross-coupling reactions and directed ortho-metalation strategies have been employed to introduce the required functional groups efficiently. These advances in synthetic chemistry have made it possible to explore more complex derivatives of this compound without significant challenges.

Recent studies have also focused on the environmental and toxicological profile of 2,4-Dichloro-3-methylmandelic acid. Understanding its behavior in biological systems is crucial for assessing its potential as a drug candidate or a chemical intermediate. Toxicological studies have examined its effects on various cell lines and organisms to evaluate its safety profile. Additionally, efforts have been made to develop green chemistry approaches for its synthesis to minimize environmental impact.

The pharmaceutical industry continues to invest in research related to 2,4-Dichloro-3-methylmandelic acid due to its promising applications. Collaborative efforts between academic institutions and pharmaceutical companies aim to uncover new uses for this compound and its derivatives. The growing body of literature on this topic underscores its importance in modern drug discovery and development.

In conclusion,2,4-Dichloro-3-methylmandelic acid (CAS No. 1803779-89-6) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and reactivity make it a valuable tool for synthesizing novel therapeutic agents. As research progresses, the potential applications of this compound are expected to expand further, contributing to the development of new treatments for various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)